NATURAL-KILLER-CELL ACTIVITY IN A PATIENT WITH CHEDIAK-HIGASHI-SYNDROME SUBMITTED TO BONE-MARROW TRANSPLANTATION

被引：4

作者：

DIAMOND, HR

SOUZA, MHFO

SILVA, MLM

TABAK, DG

FERMAN, S

MSILVA, VM

DELAROCQUE, L

RUMJANEK, VM

机构：

[1] STATE UNIV RIO DE JANEIRO,DEPT PATHOL,RIO JANEIRO,BRAZIL

[2] INST NACL CANC,BASIC RES CTR,BR-20230130 RIO JANEIRO,BRAZIL

[3] FED UNIV RIO DE JANEIRO,INST BIOPHYS,RIO JANEIRO,BRAZIL

来源：

PEDIATRIC HEMATOLOGY AND ONCOLOGY | 1995年 / 12卷 / 04期

关键词：

D O I：

10.3109/08880019509029591

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：399 / 402

页数：4

共 10 条

[1] NATURAL-KILLER (HNK-1+) CELLS IN CHEDIAK-HIGASHI PATIENTS ARE PRESENT IN NORMAL NUMBERS BUT ARE ABNORMAL IN FUNCTION AND MORPHOLOGY [J].

ABO, T ;

RODER, JC ;

ABO, W ;

COOPER, MD ;

BALCH, CM .

JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (01) :193-197

[2] NATURE OF NATURAL-KILLER CELL HYPORESPONSIVENESS IN THE CHEDIAK-HIGASHI-SYNDROME [J].

BRAHMI, Z .

HUMAN IMMUNOLOGY, 1983, 6 (01) :45-52

[3] CHEDIAK-HIGASHI GENE IN HUMANS .1. IMPAIRMENT OF NATURAL-KILLER FUNCTION [J].

HALIOTIS, T ;

RODER, J ;

KLEIN, M ;

ORTALDO, J ;

FAUCI, AS ;

HERBERMAN, RB .

JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 151 (05) :1039-1048

[4]

KATZ P, 1982, J IMMUNOL, V129, P297

[5] CHEDIAK-HIGASHI GENE IN HUMANS .2. THE SELECTIVITY OF THE DEFECT IN NATURAL-KILLER AND ANTIBODY-DEPENDENT CELL-MEDIATED CYTO-TOXICITY FUNCTION [J].

KLEIN, M ;

RODER, J ;

HALIOTIS, T ;

KOREC, S ;

JETT, JR ;

HERBERMAN, RB ;

KATZ, P ;

FAUCI, AS .

JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 151 (05) :1049-1058

[6] RAPID REAPPEARANCE OF LARGE ANTIGRANULOCYTES LYMPHOCYTES (LGL) WITH CONCOMITANT RECONSTITUTION OF NATURAL-KILLER (NK) ACTIVITY AFTER HUMAN-BONE MARROW TRANSPLANTATION (BMT) [J].

NIEDERWIESER, D ;

GASTL, G ;

RUMPOLD, H ;

MARTH, C ;

KRAFT, D ;

HUBER, C .

BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (03) :301-305

[7]

RODER JC, 1983, CLIN EXP IMMUNOL, V51, P359

[8]

Souza Maria Helena Ornellas De, 1994, European Journal of Haematology, V53, P150

[9]

TARGAN SR, 1983, J IMMUNOL, V130, P2671

[10]

VIRELIZIER JL, 1982, NEW ENGL J MED, V306, P1055

← 1 →